New synthetic ligands for L-type voltage-gated calcium channels.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-3-0348-7147-1_7PMID 8395066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nimodipine

  2018cited by this paper
• Amlodipine

  2012cited by this paper
• Felodipine

  2012cited by this paper
• Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart

  2005cited by this paper
• Non invasive study of systemic and regional haemodynamic and cardiac effects of a new calcium antagonist, SR 33557, in healthy volunteers

  2004cited by this paper
• Dual effect of 1.4-dihydropyridines on Ca2+ inflow into rat pancreatic islet cells

  2004cited by this paper
• Hypertension: Pathophysiology, Diagnosis, and Management

  1994cited by this paper
• Nimodipine

  1992cited by this paper
• Native-type DHP-sensitive calcium channel currents are produced by cloned rat aortic smooth muscle and cardiac alpha 1 subunits expressed in Xenopus laevis oocytes and are regulated by alpha 2- and beta-subunits.

  1992cited by this paper
• E4080 has a dual action, as a K+ channel opener and a Ca2+ channel blocker, in canine coronary artery smooth muscle.

  1992cited by this paper
• The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels.

  1992cited by this paper
• OPC‐13340, a New Dihydropyridine Calcium Channel Blocker Attenuates Rapid Vascular Smooth Muscle Cell Growth in Spontaneously Hypertensive Rats

  1992cited by this paper
• Drugs acting on calcium channels: potential treatment for ischaemic stroke.

  1992cited by this paper
• Antiarrhythmic and electrophysiological effects of SD-3212, a novel Na+ and Ca++ channel blocker, in anaesthetized dogs with myocardial infarction in comparison with its stereoisomer (SD-3211) and bepridil

  1992cited by this paper
• The dihydropyridine niguldipine inhibits T-type Ca2+ currents in atrial myocytes

  1992cited by this paper
• AE0047, a new dihydropyridine Ca2+ entry blocker, inhibits the responses to adrenergic nerve stimulation and substance P in dog mesenteric arteries.

  1992cited by this paper
• Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists

  1992cited by this paper
• β-Subunit expression is required for cAMP-dependent increase of cloned cardiac and vascular calcium channel currents

  1992cited by this paper
• Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.

  1992cited by this paper
• Cardiovascular Effects of a Novel Calcium Entry Blocking and Selective prAdrenoceptor Blocking Agent, YM‐16151–4, in Anesthetized and Conscious Dogs

  1992cited by this paper
• A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats.

  1992cited by this paper
• A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.

  1992cited by this paper
• On the mechanism of papaverine inhibition of the voltage-dependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea.

  1992cited by this paper
• Reduction of exercise-induced regional contractile dysfunction in dogs using a novel calcium channel blocker (Ro 40-5967)

  1992cited by this paper
• Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.

  1992cited by this paper
• Receptor sites for Ca2+ channel antagonists.

  1992cited by this paper
• Dihydropyridine binding of the calcium channel complex from skeletal muscle is modulated by subunit interaction.

  1992cited by this paper
• Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.

  1992cited by this paper
• Calcium Antagonistic and Binding Properties of Semotiadil (SD‐3211), a Benzothiazine Derivative Assessed in Cerebral and Coronary Arteries

  1992cited by this paper
• Functional interactions between two Ca2+ channel activators, (S)-Bay K 8644 and FPL 64176, in smooth muscle.

  1992cited by this paper
• Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinones.

  1992cited by this paper
• Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituents.

  1992cited by this paper
• Calcium Antagonists in Clinical Medicine

  1992cited by this paper
• Isradipine—A Review of Its Antihypertensive and Other Properties

  1992cited by this paper
• Effect of a novel calcium antagonist AE0047 on several models of cerebral ischemia

  1992cited by this paper
• Long-acting dihydropyridine calcium antagonists. Part 8. A comparison of the pharmacological and pharmacokinetic properties of amlodipine with its carba and thio-bioisosteres

  1992cited by this paper
• Native‐type DHP‐sensitive calcium channel currents are produced by cloned rat aortic smooth muscle and cardiac α1 subunits expressed in Xenopus laevis ooeytes and are regulated by α2‐ and β‐subunits

  1992cited by this paper
• Enantioselective synthesis of calcium channel blockers of the diltiazem group

  1992cited by this paper
• Interaction of charged and uncharged calcium channel antagonists with phospholipid membranes. Binding equilibrium, binding enthalpy, and membrane location.

  1991cited by this paper
• A new class of calcium antagonists. Synthesis and biological activity of 11-[(omega-aminoalkanoyl)amino]-6,6a,7,8,9,10,10a,11-octahydrodibenzo [b,e]thiepin derivatives.

  1991cited by this paper
• SD‐3211, a Novel Benzothiazine Calcium Antagonist, Alone and in Combination with a Beta‐Adrenoceptor Antagonist, Produces Antihypertensive Effects Without Affecting Heart Rate and Atrioventricular Conduction in Conscious Renal Hypertensive Dogs

  1991cited by this paper
• Long-acting dihydropyridine calcium antagonists. 6. Structure-activity relationships around 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-[(2-hydroxyethoxy)methyl]-5 -(methoxycarbonyl)-6-methyl-1,4-dihydropyridine.

  1991cited by this paper
• Diproteverine (BRL 40015): a new type of calcium antagonist with potential antianginal properties.

  1991cited by this paper
• Cardiovascular effects of E4080, a novel bradycardiac agent with coronary vasodilating properties, in anesthetized dogs.

  1991cited by this paper
• Synthetic Organic Ligands active at Voltage‐Gated Calcium Channels a

  1991cited by this paper
• Sites, mechanisms of action, and differentiation of calcium channel antagonists.

  1991cited by this paper
• A potent nonpeptide antagonist of the substance P (NK1) receptor.

  1991cited by this paper
• Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.

  1991cited by this paper
• Calcium Channels: Their Properties, Functions, Regulation, and Clinical Relevance

  1991cited by this paper
• Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy.

  1991cited by this paper
• Molecular diversity of voltage-dependent Ca2+ channels.

  1991cited by this paper
• Cardiovascular and renal actions of AHR-16303B, an antagonist of 5-HT2 receptors and calcium channels, in hypertensive and normotensive rats.

  1991cited by this paper
• Calcium Antagonism by KB‐2796, a New Diphenylpiperazine Analogue, in Dog Vascular Smooth Muscle

  1991cited by this paper
• Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium

  1991cited by this paper
• Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.

  1991cited by this paper
• Effect of a new calcium entry blocker, NB-818, on delayed neuronal death in the ischemic gerbil hippocampus.

  1991cited by this paper
• Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.

  1991cited by this paper
• Characterization of Ca2+-Antagonistic Effects of Three Metabolites of the New Antihypertensive Agent Naftopidil, (naphthyl)Hydroxy‐Naftopidil, (phenyl)Hydroxy‐Naftopidil and O-Desmethyl‐Naftopidil

  1991cited by this paper
• The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582.

  1991cited by this paper
• Long-acting dihydropyridine calcium antagonists. 9. Structure activity relationships around amlodipine

  1991cited by this paper
• Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.

  1991cited by this paper
• Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.

  1991cited by this paper
• Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites.

  1991cited by this paper
• Characterization of the slow calcium channel binding sites for [3H]SR 33557 in rat heart sarcolemmal membranes.

  1991cited by this paper
• Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.

  1991cited by this paper
• Cardiovascular effects of E4080, a novel bradycardiac agent with coronary vasodilating properties, in anesthetized dogs.

  1991cited by this paper
• Characterization of a novel, hydrophilic dihydropyridine, NKY‐722, as a Ca2+ antagonist in bovine cultured adrenal chromaffin cells

  1991cited by this paper
• Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.

  1991cited by this paper
• A new class of calcium antagonists. 2. Synthesis and biological activity of 11-[[4-[4-(4-fluorophenyl)-1-piperazinyl]butyryl]amino]-6,11- dihydrodibenzo[b,e]-thiepin maleate and related compounds.

  1991cited by this paper
• Aminoalkynyldithianes. A new class of calcium channel blockers.

  1991cited by this paper
• Long-acting dihydropyridine calcium antagonists. 7. Compounds containing unsaturation in the 2-substituent on the 1,4-dihydropyridine ring

  1991cited by this paper
• Excitation-contraction coupling in vertebrate skeletal muscle: a tale of two calcium channels.

  1991cited by this paper
• Repression, health care and ethics under apartheid.

  1991cited by this paper
• Naftopidil, a New α‐Adrenoceptor Blocking Agent with Calcium Antagonistic Properties: Characterization of Ca2+ Antagonistic Effects

  1991cited by this paper
• Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.

  1991cited by this paper
• Inhibition of calcium entry induced by cularines and isocrasifoline in uterine smooth muscle.

  1991cited by this paper
• Effect of accumulation of NKY-722, a water-soluble vasoselective Ca++ antagonist, on KCl-induced contraction in isolated canine mesenteric arteries.

  1991cited by this paper
• Cardiovascular profile of the new dihydropyridine derivative S12968.

  1991cited by this paper
• AHR‐16303B, a Novel Antagonist of 5‐HT2 Receptors and Voltage‐Sensitive Calcium Channels

  1991cited by this paper
• Ca2+ channel inhibition by a new dihydropyridine derivative, S11568, and its enantiomers S12967 and S12968.

  1990cited by this paper
• The effects of (−)‐daurisoline on Ca2+ influx in presynaptic nerve terminals

  1990cited by this paper
• SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.

  1990cited by this paper
• Calcium channels in vertebrate cells.

  1990cited by this paper
• Synthesis and Ca2+ antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H- 1,4-benzothiazines.

  1990cited by this paper
• Structure and hypotensive activity relationships of tetrandrine derivatives in stroke-prone spontaneously hypertensive rats.

  1990cited by this paper
• New ligands for L-type Ca2+ channels.

  1990cited by this paper
• Anti‐proliferative activity of L‐651,582 correlates with calcium‐mediated regulation of nucleotide metabolism at phosphoribosyl pyrophosphate synthetase

  1990cited by this paper
• Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine.

  1990cited by this paper
• L651582: a novel antiproliferative and antimetastasis agent.

  1990cited by this paper
• Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

  1990cited by this paper
• Long-acting dihydropyridine calcium antagonists. 5. Synthesis and structure-activity relationships for a series of 2-[[(N-substituted-heterocyclyl)ethoxy]methyl]-1,4-dihydropyridine calcium antagonists.

  1990cited by this paper
• Toward an understanding of the dihydropyridine-sensitive calcium channel.

  1990cited by this paper
• Mechanism of action of clentiazem on human coronary artery and myocardium

  1990cited by this paper
• Isradipine

  1990cited by this paper
• Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.

  1990cited by this paper
• Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists.

  1990cited by this paper
• Actions of Ca2+ antagonists on two types of Ca2+ channels in rat aorta smooth muscle cells in primary culture.

  1990cited by this paper
• Synthesis of benzazepinone and 3-methylbenzothiazepinone analogs of diltiazem

  1990cited by this paper
• Effects of pinaverium on voltage‐activated calcium channel currents of single smooth muscle cells isolated from the longitudinal muscle of the rabbit jejunum

  1990cited by this paper
• Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.

  1990cited by this paper

• Calcium inhibitor inhibits high glucose-induced hypertrophy of H9C2 cells

  2020cites this paper
• US 6 , 333 , 342 B 1 3 Exertional Angina

  2017cites this paper
• Calcium Uptake Inhibition Activity

  2015cites this paper
• Parallel Synthesis of Structurally Diverse Aminobenzimidazole Tethered Sultams and Benzothiazepinones.

  2012cites this paper
• Synthesis, characterization and anticancer activity of 3-aza-analogues of DP-7

  2011cites this paper
• Cardiovascular Activity

  2008cites this paper
• Advanced Dihydropyridines as Novel Multidrug Resistance Modifiers and Reversing Agents

  2007cites this paper
• L-type calcium channels.

  2006cites this paper
• Pharmacology of Cav1 (L-Type) Channels

  2004cites this paper
• Calcium channel blockers and calcium channels

  2004cites this paper
• Pharmacology of Cav3 (T-Type) Channels

  2004cites this paper
• Drug Targets in the Voltage-Gated Calcium Channel Family: Why Some Are and Some Are Not

  2003cites this paper
• Calcium involvement in the luminescence control of three ophiuroid species (Echinodermata).

  2002cites this paper
• Calciseptine, a Ca2+ Channel Blocker, Has Agonist Actions on L-type Ca2+ Currents of Frog and Mammalian Skeletal Muscle

  2001cites this paper
• Voltage-gated T-type Ca2+ channels and heart failure.

  1999cites this paper
• The pharmacology of ion channels: with particular reference to voltage-gated Ca2+ channels.

  1999cites this paper
• L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil

  1999cites this paper
• Discovery and main pharmacological properties of mibefradil (Ro 40‐5967), the first selective T‐type calcium channel blocker

  1997cites this paper
• Mibefradil: A New Selective T-Channel Calcium Antagonist for Hypertension and Angina Pectoris

  1997cites this paper
• Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker.

  1997cites this paper
• T-Type Ca2+ Channels and Pharmacological Blockade: Potential Pathophysiological Relevance

  1997cites this paper
• Novel benzamil-sensitive sodium-independent choline transport in the cestode Hymenolepis diminuta: evidence for sodium channels uptake at low pH.

  1997cites this paper
• Ion channels as pharmacologic receptors: the chirality of drug interactions.

  1996cites this paper
• Pharmacology of calcium channel antagonists

  1996cites this paper
• Developmental changes in the inducibility of fos-like immunoreactivity in primary embryonic spinal cord cultures.

  1995cites this paper
• Novel Aspects of the Pharmacology of Calcium Channel Modulators

  1995cites this paper
• The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissue.

  1995cites this paper
• Molecular Pharmacology of Voltage‐Gated Calcium Channels

  1994cites this paper
• Activators of voltage‐dependent L‐type calcium channels

  1994cites this paper
• On the other hand: the stereoselectivity of drug action at ion channels.

  1994cites this paper
• 1,4-Dihydropyridines and the 1,4-Dihydropyridine Receptor

  1993cites this paper